{"disease":{"id":"adverse-drug-interaction","name":"adverse drug interaction"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05307666","title":"MinMed: Do Older Adults do Better With Less Medication","phase":"PHASE4","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":1800,"lead_sponsor_name":"University of Alberta","has_results":false},{"nct_id":"NCT07216846","title":"The Geriatric Emergency Department Pharmacologic Harm Prevention Project","phase":"NA","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Florida Atlantic University","has_results":false},{"nct_id":"NCT03123640","title":"Improving Drug Safety in Emergency Patients -a Randomized Controlled Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":806,"lead_sponsor_name":"Diakonhjemmet Hospital","has_results":false},{"nct_id":"NCT05512169","title":"Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia","phase":"","overall_status":"RECRUITING","enrollment_count":556,"lead_sponsor_name":"University of Geneva, Switzerland","has_results":false},{"nct_id":"NCT04899960","title":"Drug-Related Problems in Neonatal Patients","phase":"NA","overall_status":"UNKNOWN","enrollment_count":512,"lead_sponsor_name":"Hacettepe University","has_results":false},{"nct_id":"NCT06244706","title":"QSPainRelief-STRAT","phase":"NA","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Université Catholique de Louvain","has_results":false},{"nct_id":"NCT06554288","title":"Pharmacogenomic Contributions to Trihexyphenidyl Biotransformation and Response in Children With Dystonic Cerebral Palsy","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Children's Mercy Hospital Kansas City","has_results":false},{"nct_id":"NCT04397445","title":"Clinical Study to Investigate the Urinary Excretion of N-nitrosodimethylamine (NDMA) After Ranitidine Administration","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Food and Drug Administration (FDA)","has_results":true},{"nct_id":"NCT03886701","title":"Doravirine, Rifapentine and Isoniazid Interaction","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"Walter K. Kraft","has_results":true},{"nct_id":"NCT04984538","title":"Implementation of a Pharmacist-led Pharmacogenomic Clinical Service","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Tabula Rasa HealthCare","has_results":false}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}